Antimicrobial Susceptibility of Pseudomonas aeruginosa to Ceftazidime-Avibactam, Ceftolozane-Tazobactam, Piperacillin-Tazobactam, and Meropenem Stratified by U.S. Census Divisions: Results from the 2017 INFORM Program

Pseudomonas aeruginosa isolates (n = 1,909) were collected from 70 U.S. medical centers, and their susceptibilities were tested using the broth microdilution method. Ceftazidime-avibactam (MIC(50)/MIC(90), 2/8 mg/liter) and ceftolozane-tazobactam (MIC(50)/MIC(90), 0.5/2 mg/liter) were the most activ...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Sader, Helio S., Flamm, Robert K., Carvalhaes, Cecilia G., Castanheira, Mariana
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2018
Sujets:
Epidemiology and Surveillance
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6256773/
https://ncbi.nlm.nih.gov/pubmed/30224535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01587-18
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires